Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells

od Lloyd, Rebecca L., Wijnhoven, Paul W. G., Ramos-Montoya, Antonio, Wilson, Zena, Illuzzi, Giuditta, Falenta, Katarzyna, Jones, Gemma N., James, Neil, Chabbert, Christophe D., Stott, Jonathan, Dean, Emma, Lau, Alan, Young, Lucy A.
Izdano u Oncogene (2020)

Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes

od Powley, Ian R., Kondrashov, Alexander, Young, Lucy A., Dobbyn, Helen C., Hill, Kirsti, Cannell, Ian G., Stoneley, Mark, Kong, Yi-Wen, Cotes, Julia A., Smith, Graeme C.M., Wek, Ron, Hayes, Christopher, Gant, Timothy W., Spriggs, Keith A., Bushell, Martin, Willis, Anne E.
Izdano 2009

pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry

od Jones, Gemma N., Rooney, Claire, Griffin, Nicola, Roudier, Martine, Young, Lucy A., Garcia-Trinidad, Antonio, Hughes, Gareth D., Whiteaker, Jeffrey R., Wilson, Zena, Odedra, Rajesh, Zhao, Lei, Ivey, Richard G., Howat, William J., Harrington, Elizabeth A., Barrett, J. Carl, Ramos-Montoya, Antonio, Lau, Alan, Paulovich, Amanda G., Cadogan, Elaine B., Pierce, Andrew J.
Izdano u Br J Cancer (2018)